Stay updated on DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Sign up to get notified when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.

Latest updates to the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedTwo new versions (2023-11-14 and 2025-03-07) were added to the Record History, capturing updates to Recruitment Status, Study Status, and Contacts/Locations.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference12%

- Check48 days agoChange DetectedThe page updates the software revision from v3.0.2 to v3.1.0, indicating a new release with potential feature/fix changes.SummaryDifference0.3%

- Check63 days agoChange DetectedUpdated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.7%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.7%

- Check77 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference10%

Stay in the know with updates to DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab
Enter your email address, and we'll notify you when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.